H.U. Group Holdings Inc. (4544)
Market Closed
10 Aug, 06:00
JPX JPX Primary 
TWSE ¥
3,536. 00
+61
+1.7554%
¥
207.39B Market Cap
- P/E Ratio
126% Div Yield
210,200 Volume
- Eps
¥ 3,475
Previous Close Want to track 4544 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
4544 closed yesterday higher at ¥3,536, an increase of 1.7554% from Friday's close, completing a monthly increase of 7.3141% or ¥241. Over the past 12 months, 4544 stock gained 4.0918%.
4544 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of ¥62.
The last earnings report, released on May 14, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).
H.U. Group Holdings Inc. (4544) FAQ
What is the stock price today?
The current price is ¥3,536.00.
On which exchange is it traded?
H.U. Group Holdings Inc. is listed on JPX.
What is its stock symbol?
The ticker symbol is 4544.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 126%.
What is its market cap?
As of today, the market cap is 207.39B.
Has H.U. Group Holdings Inc. ever had a stock split?
No, there has never been a stock split.
H.U. Group Holdings Inc. Profile
| Professional Services Industry | Industrials Sector | Mr. Goki Ishikawa CEO | JPX Exchange | JP3822000000 ISIN |
| Japan Country | 5,444 Employees | 29 Sep 2026 Last Dividend | - Last Split | - IPO Date |
Overview
H.U. Group Holdings, Inc., a prominent healthcare enterprise, extends its operations across Japan, the United States, Europe, and other international markets, through a plethora of subsidiaries. The company, originally known as Miraca Holdings Inc., transitioned to its current name in July 2020 and has been a major player in the healthcare industry since its foundation in 1950. With its headquarters in Tokyo, Japan, H.U. Group is dedicated to offering comprehensive healthcare services, including lab testing and related services, in-vitro diagnostics, and healthcare-related services, catering to a diverse range of medical needs and advancing healthcare standards globally.
Products and Services
- Lab Testing and Its Related Services: This unit specializes in collecting specimens from a variety of medical institutions and conducting an array of tests in its laboratories. Services include precision testing, pre-trial setup, specimen collection and transport, measuring, result reporting, and data management, all essential for supporting medical research and development.
- In Vitro Diagnostics: Known for developing cerebrospinal fluid reagent compatible with its automated chemiluminescent enzyme immunoassay system, this segment focuses on creating reagents and biomarkers for diseases like Alzheimer's. It operates a CDMO business model, supplying key materials to leading in-vitro diagnostics companies, featuring Lumipulse for chemiluminescence-based testing and offering rapid diagnostic kits for infectious diseases such as influenza and COVID-19.
- Healthcare-related Services: This division provides a suite of services to enhance hospital operations, including in-house and external sterilization services, support for operating and endoscopy rooms, maintenance of medical equipment, and logistics management. Additionally, it engages in the sale of medical equipment and supplies, offers home medical care and nursing services, and facilitates the rental of nursing care equipment, ensuring comprehensive support for healthcare providers and patients alike.
Contact Information
Address: Shinjuku Mitsui Building
Phone: 81 3 5909 3335
Website: https://www.hugp.com
